A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-24
DOI
10.1038/s41375-019-0604-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Minimal residual disease detected by multiparameter flow cytometry is complementary to genetics for risk stratification treatment in acute myeloid leukemia with biallelic CEBPA mutations
- (2019) Dao-Xing Deng et al. LEUKEMIA & LYMPHOMA
- The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia
- (2018) Nicolas Duployez et al. LEUKEMIA
- Clinical implications of measurable residual disease in AML: Review of current evidence
- (2018) Ine Moors et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo
- (2016) C. Pabst et al. BLOOD
- GPR56 contributes to the development of acute myeloid leukemia in mice
- (2016) D Daria et al. LEUKEMIA
- A 17-gene stemness score for rapid determination of risk in acute leukaemia
- (2016) Stanley W. K. Ng et al. NATURE
- Pediatric AML: From Biology to Clinical Management
- (2015) Jasmijn de Rooij et al. Journal of Clinical Medicine
- Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
- (2014) Alan S. Gamis et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia
- (2014) C Niederwieser et al. LEUKEMIA
- High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group
- (2014) George S. Laszlo et al. LEUKEMIA & LYMPHOMA
- Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia
- (2014) Monique Terwijn et al. PLoS One
- AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia
- (2011) Todd M. Cooper et al. CANCER
- Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML
- (2011) H J M de Jonge et al. LEUKEMIA
- Stem cell gene expression programs influence clinical outcome in human leukemia
- (2011) Kolja Eppert et al. NATURE MEDICINE
- Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia
- (2010) Andrew J. Gentles JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
- (2010) Jeffrey E Rubnitz et al. LANCET ONCOLOGY
- Identification of trypsin-inhibitory site and structure determination of human SPINK2 serine proteinase inhibitor
- (2009) Ting Chen et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Avoiding infinite estimates of time-dependent effects in small-sample survival studies
- (2008) Georg Heinze et al. STATISTICS IN MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started